Scotia Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301M Sell
1,231,920
-89,336
-7% -$20.8M 1.24% 23
2025
Q4
$273M Sell
1,321,256
-12,394
-0.9% -$2.45M 1.1% 25
2025
Q3
$247M Sell
1,333,650
-21,594
-2% -$3.7M 1.05% 27
2025
Q2
$207M Buy
1,355,244
+47,938
+4% +$7.37M 0.98% 28
2025
Q1
$217M Buy
1,307,306
+4,913
+0.4% +$769K 1.16% 25
2024
Q4
$188M Buy
1,302,393
+88,196
+7% +$13.7M 0.99% 27
2024
Q3
$197M Sell
1,214,197
-17,677
-1% -$2.82M 1.05% 29
2024
Q2
$180M Buy
1,231,874
+8,333
+0.7% +$1.24M 1.05% 28
2024
Q1
$194M Buy
1,223,541
+40,507
+3% +$6.45M 1.15% 26
2023
Q4
$185M Buy
1,183,034
+12,200
+1% +$1.87M 1.2% 24
2023
Q3
$182M Sell
1,170,834
-21,431
-2% -$3.54M 1.32% 22
2023
Q2
$197M Buy
1,192,265
+48,985
+4% +$7.91M 1.35% 22
2023
Q1
$177M Buy
1,143,280
+38,133
+3% +$6.16M 1.29% 21
2022
Q4
$195M Buy
1,105,147
+17,440
+2% +$3.01M 1.5% 15
2022
Q3
$178M Buy
1,087,707
+43,570
+4% +$7.37M 1.44% 17
2022
Q2
$185M Sell
1,044,137
-9,313
-0.9% -$1.66M 1.38% 19
2022
Q1
$187M Sell
1,053,450
-23,998
-2% -$4.08M 1.18% 22
2021
Q4
$184M Buy
1,077,448
+38,190
+4% +$6.25M 1.21% 21
2021
Q3
$168M Buy
1,039,258
+41,399
+4% +$7.06M 1.22% 21
2021
Q2
$164M Buy
997,859
+7,576
+0.8% +$1.25M 1.2% 21
2021
Q1
$163M Buy
990,283
+38,714
+4% +$6.26M 1.32% 18
2020
Q4
$150M Buy
951,569
+35,227
+4% +$5.2M 1.38% 17
2020
Q3
$136M Buy
916,342
+4,234
+0.5% +$627K 1.48% 15
2020
Q2
$129M Sell
912,108
-1,708
-0.2% -$249K 1.8% 12
2020
Q1
$120M Sell
913,816
-12,006
-1% -$1.7M 1.67% 14
2019
Q4
$135M Sell
925,822
-21,991
-2% -$2.98M 1.5% 16
2019
Q3
$123M Buy
947,813
+15,411
+2% +$2.03M 1.44% 16
2019
Q2
$130M Buy
932,402
+36,156
+4% +$5M 1.58% 14
2019
Q1
$125M Sell
896,246
-23,155
-3% -$3.1M 1.61% 14
2018
Q4
$119M Buy
919,401
+13,425
+1% +$1.87M 1.75% 12
2018
Q3
$125M Buy
905,976
+77,924
+9% +$10.4M 1.59% 13
2018
Q2
$105M Buy
828,052
+11,166
+1% +$1.39M 1.47% 14
2018
Q1
$105M Buy
816,886
+99,100
+14% +$13.4M 1.44% 14
2017
Q4
$100M Buy
717,786
+6,887
+1% +$959K 1.34% 16
2017
Q3
$92.4M Buy
710,899
+78,859
+12% +$10.5M 1.32% 15
2017
Q2
$83.6M Sell
632,040
-3,796
-0.6% -$484K 1.41% 14
2017
Q1
$79.3M Sell
635,836
-76,285
-11% -$9.11M 1.35% 15
2016
Q4
$82.1M Buy
712,121
+52,611
+8% +$6.08M 1.31% 16
2016
Q3
$77.9M Buy
659,510
+35,232
+6% +$4.27M 1.43% 14
2016
Q2
$75.9M Sell
624,278
-13,440
-2% -$1.53M 1.54% 12
2016
Q1
$69.1M Buy
637,718
+22,354
+4% +$2.31M 1.51% 15
2015
Q4
$63.2M Hold
615,364
1.43% 15
2015
Q3
$57.5M Buy
615,364
+7,157
+1% +$692K 1.3% 15
2015
Q2
$59.1M Buy
608,207
+53,363
+10% +$5.34M 1.19% 15
2015
Q1
$55.8M Buy
554,844
+22,515
+4% +$2.29M 1.44% 13
2014
Q4
$55.6M Sell
532,329
-51,611
-9% -$5.44M 1.46% 14
2014
Q3
$62.2M Buy
583,940
+38,480
+7% +$3.99M 1.33% 17
2014
Q2
$57.1M Sell
545,460
-90,413
-14% -$9.14M 1.23% 17
2014
Q1
$62.4M Buy
635,873
+132,584
+26% +$12.3M 1.39% 16
2013
Q4
$46.1M Buy
503,289
+2,210
+0.4% +$204K 1.1% 18
2013
Q3
$43.5M Buy
501,079
+105,506
+27% +$9.47M 1.16% 16
2013
Q2
$34M Buy
+395,573
New +$33.6M 1.31% 16

Other funds holding JNJ

Scotia Capital's JNJ Position: Q1 2026 in Review

Scotia Capital reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q1 2026, selling an estimated $20.8M and leaving 1,231,920 shares worth $301M. The position accounts for 1.24% of the portfolio, ranked #23.

Scotia Capital first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Scotia Capital held 1,231,920 shares of Johnson & Johnson worth $301M as of Q1 2026.
  • Scotia Capital sold 89,336 Johnson & Johnson shares in Q1 2026, an estimated $20.8M.
  • Johnson & Johnson made up 1.24% of Scotia Capital's portfolio in Q1 2026, its #23 holding.
  • Scotia Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.